首页 › 基金 › Meritage Group LP › NEPH
Meritage Group LP 对 NEPH 的持仓历史
NEPHROS INC · 医疗保健
Meritage Group LP 在 Q3 2026 的 13F 申报中披露持有 NEPH(NEPHROS INC)173,407 股,市值约 US$643K,约占其申报组合的 0.02%,在其申报持仓中市值排名第 13 位。 Meritage Group LP 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Meritage Group LP 对 NEPH 的持仓演变
Meritage Group LP 于 Q3 2026 首次披露 NEPH 持仓:173,407 股(约 US$643K)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 173.41K | $643.34K | 新进 |
关于 NEPH 与 13F 数据
NEPH(NEPHROS INC)属于医疗保健行业。我们追踪的基金中还有 33 只申报持有 NEPH,申报仓位最大的包括:Topline Capital Management, LLC (US$1.9M), MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US$1.3M), ELKHORN PARTNERS LIMITED PARTNERSHIP (US$41K)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 NEPH 的基金
- Topline Capital Management, LLC 535.70K 股 · $1.91M · Q2 2026
- MASSACHUSETTS INSTITUTE OF TECHNOLOGY 346.81K 股 · $1.29M · Q3 2026
- ELKHORN PARTNERS LIMITED PARTNERSHIP 11.00K 股 · $40.81K · Q3 2026
更多关于 Meritage Group LP
常见问题
How long has Meritage Group LP held NEPH?
Meritage Group LP has disclosed NEPH holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Meritage Group LP's current position in NEPH?
As of Q3 2026, Meritage Group LP holds 173.41K shares of NEPH (NEPHROS INC), valued at $643.34K, representing 0.02% of its reported portfolio and ranking #13.
Has Meritage Group LP been buying or selling NEPH?
In the latest 13F filing (Q3 2026), Meritage Group LP newly opened its position in NEPH.
Which other funds hold NEPH?
Other major institutional holders of NEPH include Topline Capital Management, LLC, MASSACHUSETTS INSTITUTE OF TECHNOLOGY, ELKHORN PARTNERS LIMITED PARTNERSHIP, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.